TrialPulmonary pharmacology & therapeutics2021
Tofacitinib reduces mortality in coronavirus disease 2019 Tofacitinib in COVID-19.
Roman Maslennikov et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
28 papers cite it
this paperpooled ittrialcites it